US FDA Issues Guidance Outlining Process For Requesting DSCSA Waivers

Pharmaceutical manufacturers now have, at long last, guidance from FDA on the process for applying for exceptions and waivers under DSCSA. Yet they don't have much time to act as the new serialization requirements go into effect this November. Exception requests have to be submitted soon.